Analgesic Effect of Oxytocin Receptor Modulation in Healthy Volunteers
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2015
Price : $35 *
At a glance
- Drugs Carbetocin (Primary)
- Indications Hyperalgesia; Pain
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 11 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Sep 2014 Planned End Date changed from 1 Jun 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov.